Related Experiment Video
Updated: Mar 6, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Iron Deficiency and Iron Deficiency Anemia in 3-5 months-old, Breastfed Healthy Infants
Sudarsan Krishnaswamy1, Dharmagat Bhattarai1, Bhavneet Bharti2
1Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Insights
Iron deficiency (ID) and iron deficiency anemia (IDA) are prevalent in exclusively breastfed infants by 4-5 months. This study suggests considering iron supplementation earlier than the standard 6 months.
Area of Science:
- Pediatrics
- Nutritional Science
- Hematology
Background:
- Iron deficiency (ID) and iron deficiency anemia (IDA) pose significant health risks in infants.
- Early detection and intervention are crucial for infant development.
Purpose of the Study:
- To determine the prevalence of ID and IDA in predominantly breastfed, term infants aged 3-5 months.
- To evaluate the need for early iron supplementation.
Main Methods:
- A cross-sectional study was conducted on 215 infants (90-180 days old) meeting specific inclusion criteria.
- Iron deficiency was defined as serum ferritin <12 μg/L, and IDA as ID with Hb ≤10.5 g/dL.
Main Results:
- The prevalence of ID increased from 5.4% at 3 months to 36.4% at 5 months.
- IDA prevalence was 4.6% at 3 months, peaking at 16.7% at 4 months, then decreasing to 11.4% at 5 months.
- Significant ID prevalence at 4 and 5 months (21.4% and 36.4%) was observed.
Conclusions:
- High prevalence of ID in predominantly breastfed, term infants by 4-5 months.
- Evidence supports considering iron supplementation from 4 months of age, earlier than the current recommendation of 6 months.
Objective:
To assess the prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) in predominantly breastfed, 3-5-mo-old infants, born at term, with a birth weight ≥ 2.5 kg.
Methods:
The cross-sectional study was conducted in the outpatient department of a tertiary care center from January 2013 through December 2014.
Inclusion Criteria:
Age: 90-180 d, exclusively/predominantly breastfed, birth weight ≥ 2.5 kg and term gestation.
Exclusion Criteria:
systemic illness, leucocytosis, leucopenia, thrombocytopenia, peripheral smear abnormality or iron supplementation. Blood sample was collected for complete blood count and ferritin assay. ID was defined as serum ferritin <12 μg/L. IDA was defined as ID plus Hb ≤ 10.5 g/dl.
Results:
Two hundred ninety six infants were initially recruited; 29 declined consent; 22 had leukocytosis, leucopenia or eosinophilia; 15 had thrombocytopenia; 15 samples were hemolyzed or insufficient. Finally, 215 infants were evaluated. The male-female ratio was 1.8:1. The mean birth weight was 2.9 (0.4) kg. The mean Hb was 10.8 (1.2) g/dl. The median serum ferritin was 44 μg/L (18, 120). The prevalence of ID at 3, 4 and 5 mo of age was 5.4%, 21.4% and 36.4%, while that of IDA was 4.6%, 16.7% and 11.4%, respectively.
Conclusions:
The prevalence of ID at 4 and 5 mo of age in predominantly breastfed, term infants was 21.4% and 36.4%, respectively. The study generates evidence for considering iron supplementation for well-babies from 4 mo of age, instead of the currently recommended 6 mo by National Iron plus Initiative in India.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children
Vitamins
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism

